Skip to main content

Table 2 Antibiotic agents prescribed among the study hospitals (% of prescribed antibiotics)

From: Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan

  Medical   surgical  
Antibiotic prescriptions (ATC4) Antrim Area Hospital (n = 239 antibiotic prescriptions) n (%) Specialty Hospital (n = 65 antibiotic prescriptions) n (%) p value Antrim Area Hospital (n = 66 antibiotic prescriptions) n (%) Specialty Hospital (n = 56 antibiotic prescriptions) n (%) p value
Intestinal anti-infectives (antibiotics) (A07AA) 6 (2.5) 0 (0.0) 0.197 0 (0.0) 0 (0.0) n/a
Tetracyclines (J01AA) 21 (8.8) 3 (4.6) 0.269 1 (1.5) 2 (3.6) 0.465
Penicillins with extended spectrum (J01CA) 45 (18.8) 0 (0.0) < 0.001 9 (13.6) 0 (0.0) 0.004
Beta-lactamase sensitive penicillins (J01 CE) 4 (1.7) 0 (0.0) 0.294 0 (0.0) 0 (0.0) n/a
Beta-lactamase resistant penicillins (J01CF) 10 (4.2) 0 (0.0) 0.094 2 (3.0) 0 (0.0) 0.189
Combinations of penicillins, including b-lactamase inhibitors (J01CR) 45 (18.8) 8 (12.3) 0.219 13 (19.7) 4 (7.1) 0.046
First-generation cephalosporins (J01DB) 1 (0.4) 1 (1.5) 0.322 1 (1.5) 2 (3.6) 0.465
Second-generation cephalosporins (J01 DC) 4 (1.7) 0 (0.0) 0.294 0 (0.0) 2 (3.6) 0.122
Third-generation cephalosporins (J01DD) 5 (2.1) 17 (26.2) < 0.001 0 (0.0) 21 (37.5) < 0.001
Monobactams (J01DF), 7 (2.9) 0 (0.0) 0.163 0 (0.0) 0 (0.0) n/a
Carbapenems (J01DH) 3 (1.3) 10 (15.4) < 0.001 1 (1.5) 12 (21.4) < 0.001
Trimethoprim and derivatives (J01EA) 4 (1.7) 0 (0.0) 0.294 1 (1.5) 0 (0.0) 0.355
Combination of trimethoprim/sulfamethoxazole (J01EE) 6 (2.5) 0 (0.0) 0.197 0 (0.0) 0 (0.0) n/a
Macrolides (J01FA) 23 (9.6) 3 (4.6) 0.201 0 (0.0) 0 (0.0) n/a
Aminoglycosides (J01GB) 11 (4.6) 6 (9.2) 0.150 13 (19.7) 1 (1.8) 0.002
Fluoroquinolones (J01MA) 3 (1.3) 12 (18.5) < 0.001 2 (3.0) 3 (5.4) 0.518
Glycopeptide antibacterials (J01XA) 12 (5.0) 2 (3.1) 0.507 4 (6.1) 7 (12.5) 0.216
Steroid antibacterials (J01XC) 1 (0.4) 0 (0.0) 0.601 0 (0.0) 0 (0.0) n/a
Imidazole derivatives (J01XD) 18 (7.5) 2 (3.1) 0.199 16 (24.2) 2 (3.6) 0.001
Nitrofuran derivatives (J01XE) 2 (0.8) 0 (0.0) 0.459 0 (0.0) 0 (0.0) n/a
Other antibacterials (J01XX) 0 (0.0) 1 (1.5) 0.055 1 (1.5) 0 (0.0) 0.355
Antimycotics, triazole derivatives (J02 AC) 2 (0.8) 0 (0.0) 0.459 0 (0.0) 0 (0.0) n/a
Antimycotics, other antimycotics for systematic use (J02AX) 1 (0.4) 0 (0.0) 0.601 0 (0.0) 0 (0.0) n/a
Antimycobacterials, antibiotics (J04AB) 5 (2.1) 0 (0.0) n/a 0 (0.0) 0 (0.0) n/a
Antivirals, neuraminidase inhibitors (J05AH) 0 (0.0) 0 (0.0) n/a 0 (0.0) 0 (0.0) n/a
Antiprotozoals, nitroimidazole derivatives (P01AB) 5 (2.1) 1 (0.8) 0.240 2 (3.0) 0 (0.0) 0.189
  1. n/a: not applicable